Practically, the biological diagnosis of AD would require low concentrations of Aβ42 and high concentrations of p-tau in the CSF or positivity on amyloid-PET (positron emission tomography) and tau-PET (Table 1). This evidence concerns the gene MAPT and Alzheimer disease.